Stratasys Unveils New Software and Materials to Enhance Additive Manufacturing
Stratasys unveiled a slate of new application-driven software capabilities, materials, and platform enhancements designed to empower manufacturers to push additive manufacturing beyond concept models and into production parts faster than ever. Stratasys will enable organizations to move the production of more parts and tools from traditional methods into additive workflows, by streamlining design and ease of use, improving reliability, and expanding materials and platform capabilities. This approach will dramatically increase speed and performance while reducing costs. The J850 Core printer expands the PolyJet(TM) technology lineup with a lower-cost system built for engineering teams focused on functional prototyping. It gives customers access to PolyJet performance and materials without paying for full-color capabilities. These advancements hit the sweet spot between capability and cost for teams that want speed and reliability at a more practical price point. The system is planned to be open for booking by the end of April.Stratasys and Shin-Etsu are introducing P3 MED Silicone 25A, the first biocompatible true silicone for 3D printing patient-specific medical devices and low-volume production parts, available exclusively on Origin printers. Fully certified to ISO 10993 standards, the material delivers authentic silicone properties such as elasticity, durability, and resistance to heat, chemicals, and aging. This combination overcomes many challenges traditionally associated with 3D printing true silicone.
Trade with 70% Backtested Accuracy
Analyst Views on SSYS
About SSYS
About the author

- Acquisition Overview: Stratasys announced an all-cash acquisition of Markforged for $42.5 million, aimed at strengthening its market position in defense and aerospace, which is expected to significantly enhance the company's technological capabilities and competitive edge.
- Technology Integration Benefits: The acquisition will add Markforged's continuous carbon fiber technology and The Digital Forge software platform to Stratasys' portfolio, thereby enhancing its application capabilities across aerospace, defense, automotive, and food and beverage industries.
- Financial Expectations: Stratasys anticipates that the deal will positively impact gross margins and be accretive to EBITDA within one year of closing, while also achieving cost synergies that will further optimize financial performance.
- Market Reaction: In pre-market trading on Nasdaq, Stratasys shares rose by 2.80% to $9.93, reflecting positive market sentiment regarding the acquisition and demonstrating investor confidence in the company's future growth potential.
- Acquisition Agreement: Stratasys has entered into a definitive agreement to acquire MarkForged, a wholly owned subsidiary of Nano Dimension, in an all-cash transaction valued at $42.5 million, expected to close in the second half of 2026, thereby enhancing Stratasys' capabilities in the aerospace and defense sectors.
- Revenue Contribution: MarkForged generated approximately $70 million in revenue in 2025, and while its Metal Binder Jetting product line will be retained by Nano Dimension, this acquisition will provide Stratasys with new distribution channels, enhancing its competitive position in the market.
- Positive Market Reaction: Following the announcement of the acquisition, Stratasys' stock rose by 1.9% in premarket trading, indicating investor optimism regarding the deal and its potential to bolster the company's long-term growth prospects.
- Future Guidance: Stratasys stated it would update its financial guidance following the completion of the transaction, reflecting the company's confidence in future performance and its strategic intent to expand in a rapidly evolving market landscape.
- Strategic Plan Advancement: Nano Dimension has announced the sale of its wholly-owned subsidiary MarkForged for $42.5 million in cash, marking a significant step in its three-phase strategic plan aimed at maximizing long-term shareholder value through business simplification and balance sheet strengthening.
- Cash Burn Reduction: The transaction is expected to reduce annualized cash burn by approximately $15 million through a combination of direct and indirect operating cost savings, thereby enhancing the company's financial health and providing more capital for future investments.
- Product Line Retention: Despite the sale of MarkForged, Nano Dimension will retain the Markforged Metal Binder Jetting product line, a decision that not only helps maintain product diversity but also ensures competitiveness in future markets.
- Future Growth Opportunities: CEO David Stehlin stated that the transaction will accelerate the execution of Phase 3, with recent discussions held with a focused set of strategic opportunities and potential partners aimed at further enhancing shareholder value and driving long-term company growth.
- Acquisition Overview: Stratasys announced a definitive agreement to acquire MarkForged for $42.5 million in cash, expected to close in the second half of 2026, significantly strengthening its market position in high-demand manufacturing applications.
- Financial Expectations: MarkForged generated approximately $70 million in revenue in 2025, and Stratasys anticipates gross margin accretion and meaningful cost synergies within one year post-transaction, enhancing positive adjusted EBITDA contributions.
- Technological Integration Benefits: By integrating MarkForged's Continuous Carbon Fiber technology, Stratasys will provide lighter and stronger production-ready components, addressing critical industry demands in aerospace and defense, thereby enhancing its competitive edge.
- Market Network Expansion: This acquisition is set to enhance Stratasys' distribution channels and market coverage, creating additional cross-sale opportunities that will improve customer service and choice, supporting its strategic positioning in a rapidly evolving manufacturing landscape.
- Strategic Progress: Nano Dimension has announced the sale of its wholly-owned subsidiary MarkForged for $42.5 million in cash, marking a significant step in its three-phase strategic plan aimed at enhancing long-term shareholder value through business simplification and balance sheet strengthening.
- Cash Burn Reduction: The transaction is expected to reduce annualized cash burn by approximately $15 million, primarily achieved through direct and indirect operating cost savings, thereby enhancing the company's financial flexibility and supporting future growth.
- Product Line Retention: Despite the sale of MarkForged, Nano Dimension will retain the Markforged Metal Binder Jetting product line, a decision that not only ensures the continued development of core technologies but also lays the groundwork for future market opportunities.
- Future Outlook: The transaction is expected to close in the second half of 2026, as Nano Dimension continues to advance its strategic plan and actively seeks strategic opportunities with potential partners to maximize long-term shareholder value.
- New Company Listing: Conexeu Sciences Inc. debuted on Nasdaq on May 21, 2026, with over 25.2 million shares issued, as CEO emphasized their CXU™ platform's goal to rebuild biological structures, potentially attracting significant investor interest in regenerative medicine.
- Significant Revenue Growth: Pacira BioSciences achieved total revenue of $726.4 million in 2025, with gross margins at a historic high of 79.4%, reflecting strong demand for its non-opioid pain therapies, which may lead to increased capital inflows into related companies.
- Bioprinting Infrastructure: Stratasys reported $237.8 million in cash and equivalents with no debt in Q1 2026, and its TrueDent® resins received CE marking, enhancing its penetration in the European market and strengthening the bioprinting industry's infrastructure.
- Wound Care Innovation: Smith & Nephew launched ALLEVYN COMPLETE CARE Foam Dressing in the U.S. in March 2026, targeting chronic wound management with robust scientific backing, addressing the growing global demand for wound care and further expanding the regenerative medicine market.









